Please login to the form below

Supercharging Communication: How Modular Content Can Improve Your Connection With Clients

Viseven to host joint webinar with Campana & Schott featuring special guests from Bayer AG

Pharma and life sciences companies often face communication issues when dealing with clients. As the main purpose of any business marketing is to deliver its message to the end user, it becomes a number one priority to design a proper communication flow.

So, solving this problem is very much easier said than done. A lack of time during face-to-face meetings, high drop rates of opened emails, and missing deadlines for campaign launch increase time-to-market, and, as a result, the production costs — these issues are just the tip of the iceberg of hurdles that affects the pharma businesses.

This is where a modular approach comes in — a content framework that helps to organize and structure the communication possibilities of your marketing team. It may look rather simple from the first look — the ordinary box of the necessary information.

Viseven is very excited to announce the upcoming webinar with Campana & Schott as well as special guests from Bayer AG. We cannot wait to see you join us for a session dedicated to the modular content approach and its business advantages. The event will take place live on Tuesday, September 6, 2022, at 15:00 CEST. 

Supercharging Communication: How Modular Content Can Improve Your Connection With Clients webinar will focus on the business solutions and ideas that come along with implementing a high-quality modular content development and distribution flow. A modular approach can be applied to a variety of marketing activities, becoming a strong and flexible solution for content development and omnichannel strategies, from email marketing campaigns to Medical, Legal, and Regulatory review. From reducing content development and production costs to creating a stable and smart ecosystem that makes communication with health care representatives easy for both pharma companies and HCP.

We are going to discuss how exactly the modular approach can be implemented and used in an everyday pharma marketing routine; how modular content helps to improve MLR approval rate and increase time-to-market, and many other topics.

The webinar will feature:

Nataliya Andriychuk, CEO at Viseven

René Kräling, Managing Consultant at Campana & Schott

Julian Hecker, Digital & Content Strategy Lead at Bayer AG

Daniel Lorenz, Content & Campaign Operations Manager Radiology at Bayer AG

Do not forget to join us this September to talk about improving communication from both customer and business perspectives.

About Viseven:

Viseven is a Global MarTech Services Provider for Pharma and Life Sciences with more than 10 years of expertise in the industry. The company's solutions, products, and services are actively used by TOP 50 Pharma and Life Sciences companies in more than 30 countries around the globe. With over 150 Veeva-certified specialists and the statuses of Veeva Silver Certified Technology Partner and Veeva DFAP Content Partner, Viseven offers custom solutions for pharmaceutical communications. We enable digital marketing transformation for enterprises of different sizes and different digital maturity levels. Our expertise covers the entire range of relevant aspects, from modular content to customer journey management, aligning tech with strategic goals.

Follow us on social media: LinkedInTwitterYouTubeFacebook

Contact us: pr@viseven.com

8th August 2022

Share

Tags

Company Details

Viseven

+37 269 80 460

Contact Website

Address:
Lõõtsa Str. 2b
Lasnamäe district
Tallinn
Harju County
11415
Estonia

Latest content on this profile

Supercharging Communication: How Modular Content Can Improve Your Connection With Clients
Viseven to host joint webinar with Campana & Schott featuring special guests from Bayer AG
Viseven
Viseven and Next Pharma Partnership Announcement
Viseven Group is happy to share its latest business venture - a partnership with NEXT. The two companies join forces to positively impact the future of the pharmaceutical industry and help healthcare providers focus their strategy on patients.
Viseven
Viseven opens a new center of excellence in India
Viseven adds another location to its vast global centers of excellence network to provide around-the-clock support for its clients
Viseven
As HCPs Increasingly Expect Personalized Engagement, Pharmas Turn to Modular Intelligent Content. How Does This Work?
While personalized omnichannel communication is becoming the only truly acceptable option in brand communications, Life Sciences are deeply affected by the change. Compared to retail, the amounts of information to deliver alongside the key message are predictably greater for a pharmaceutical product. Even without taking into consideration the “new” channels like social, messengers, etc. that are explored by pharmaceutical marketers, the amounts of content to be produced are growing. To cope with the challenge, pharmaceutical companies are looking to optimize content production and management. Several approaches are used, from establishing centralized Content Factories (hubs) to completely rethinking content as such. Modular Content (and its derivative, Smart Content) are the most promising strategy. What can already be said about it?
Viseven
Viseven is a Salesforce Consulting Partner
Viseven Group, an international end-to-end omnichannel solutions provider working for the pharmaceutical industry, is happy to announce its newly acquired status as a Salesforce Consulting Partner. The integration of Viseven’s powerful eWizard multichannel pharma content authoring platform with Salesforce allows to elevate the benchmarks even further, bringing genuine value to customers in life sciences.
Viseven
eWizard Remote Detailing: How to Eliminate Health Risks and Maintain Communication Value for Pharma During the COVID-19 Pandemic?
Since the COVID-19 crisis is now officially a pandemic, Pharma and Life Sciences are continuing to participate in the effort of mitigating the spreading of coronavirus disease in the world. Pharmaceutical companies all around the globe are looking for alternative ways to keep in touch with their audiences while minimizing the risks for the health and well-being of both medical representatives and healthcare professionals.
Viseven